Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study.

MLA

Smoot, Kyle, et al. “Clinical Outcomes of Patients with Multiple Sclerosis Treated with Ocrelizumab in a US Community MS Center: An Observational Study.” BMJ Neurology Open, vol. 3, no. 2, July 2021, p. e000108. EBSCOhost, https://doi.org/10.1136/bmjno-2020-000108.

APA

Smoot, K., Chen, C., Stuchiner, T., Lucas, L., Grote, L., & Cohan, S. (2021). Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study. BMJ Neurology Open, 3(2), e000108. https://doi.org/10.1136/bmjno-2020-000108

Chicago

Smoot, Kyle, Chiayi Chen, Tamela Stuchiner, Lindsay Lucas, Lois Grote, and Stanley Cohan. 2021. “Clinical Outcomes of Patients with Multiple Sclerosis Treated with Ocrelizumab in a US Community MS Center: An Observational Study.” BMJ Neurology Open 3 (2): e000108. doi:10.1136/bmjno-2020-000108.